The Nitrogen Is Part Of A -c=n Group Which Is Bonded Directly To The Diazole Ring (e.g., 4,5-dicyanoimidazole, Etc.) Patents (Class 548/337.1)
  • Patent number: 11795195
    Abstract: A compound represented by formula (1-1): wherein b represents an integer of 1 to 5; and Z is a group represented by formula (Z-1), formula (Z-2), formula (Z-3), formula (Za-1), formula (Za-2), formula (Za-3), formula (Za-4) or formula (Za-5), or a salt thereof.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: October 24, 2023
    Assignee: Sumitomo Pharma Co., Ltd.
    Inventors: Hitoshi Ban, Atsushi Suwa, Yosuke Takanashi
  • Publication number: 20140315079
    Abstract: A method for preparing an imidazole compound with the following formula: wherein Rf is a fluorinated alkyl group comprising between 1 and 5 carbon atoms, said method including: (a) the reaction of the diaminomaleonitrile with the following formula: with the compound with the following formula: wherein Y represents a chlorine atom or the OCORf group to form the salified amide compound with the following formula: at temperature T1, and (b) the dehydration of the salified amide compound with formula (IVa) and/or the corresponding amino (IVb) to form the imidazole compound with formula (III), at temperature T2 higher than T1.
    Type: Application
    Filed: October 29, 2012
    Publication date: October 23, 2014
    Inventors: Gregory Schmidt, Miguel Flasque
  • Patent number: 8658682
    Abstract: (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-ethanone oxime dihydrate, compositions comprising it, and methods of its use are disclosed.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: February 25, 2014
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: Wenxue Wu, Haiming Zhang
  • Publication number: 20130123287
    Abstract: Providing a novel control agent for soft rot and a novel control method for the same. A compound having no antibacterial activity against Erwinia carotovora but having a control activity against fungi on soil surface, specifically containing, as the active ingredient, a fungicide comprising any of a strobilurin compound such as azoxystrobin and kresoxim-methyl, an azole compound such as triflumizol, cyazofamid, amisulbrom, and thiophanate-methyl, a carboxamide compound such as penthiopyrad and boscalid, a sulfonamide compound such as flusulfamide, an organic chlorine compound such as chlorothalonil, a dicarboximide compound such as pro-cymidone and iprodione, a phenylpyrrole compound such as fludioxonil, an anilinopyrimidine compound such as mepanipyrim, and a guanidine compound such as iminoctadine is the control agent for plant soft rot, which is applied to plant cultivation soil.
    Type: Application
    Filed: July 21, 2011
    Publication date: May 16, 2013
    Applicant: ISHIHARA SANGYO KAISHA, LTD.
    Inventors: Koji Sugimoto, Hiroyuki Hayashi
  • Publication number: 20130012620
    Abstract: The present invention relates to curatives for epoxy resins, and compositions (e.g. adhesives) containing such resins cured using the same methods of preparation and uses therefor. More specifically, the present invention relates to hybrid curatives for epoxy resins comprising both aromatic amine, phenol and/or phenyl ester moieties. A further aspect of the current invention relates to new imidazole catalysts that possess a combination of excellent cure latency as well as low cure temperature onset.
    Type: Application
    Filed: March 16, 2011
    Publication date: January 10, 2013
    Applicant: DESIGNER MOLECULES, INC.
    Inventor: Stephen M Dershem
  • Publication number: 20120270917
    Abstract: Provided are compounds that are capable of modulating the activity of the influenza A virus via interaction with the M2 transmembrane protein. Also provided are methods for treating an influenza A-affected disease state or infection comprising administering a composition comprising one or more compounds that have been identified as being capable of interaction with the M2 protein.
    Type: Application
    Filed: July 30, 2010
    Publication date: October 25, 2012
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: William F. DeGrado, Jun Wang
  • Patent number: 8168802
    Abstract: Methods and intermediates useful for making compounds of the formula: and the preparation of compounds of Formula I, preferably including the formation of intermediate compounds of the formula:
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: May 1, 2012
    Assignee: 3M Innovative Properties Company
    Inventors: David S. Hays, Sonja S. Mackey, William H. Moser, Doris D. Stoermer, Matthew R. Radmer, Shri Niwas
  • Publication number: 20120071531
    Abstract: Process for the protection of fish and invertebrates and all their stages of development against or for the treatment of mycoses caused by fungi of the genera Saprolegnia, Aphanomyces, Achlyaflagellata and other species important in aquacultures by use of 2-[[[[1-[3-(1-fluoro-2-phenylethyl)oxy]phenyl]ethylidene]amino]oxy]methyl]alpha-(methoxyimino)-N-methyl-alphaE-benzeneacetamide, amisulbrom, cyazofamid, enestrobin, famoxadone, fenamidone, fluoxastrobin, orysastrobin, picoxystrobin and pyribencarb. This use leads to an inhibition or destruction of pathogenic fungi. The composition, comprising at least one fungicide selected from the abovementioned group for use in fish farming and keeping is suitable for the prophylaxis and therapy of diseases of fish in aquaculture, in breeding ponds, breeding tanks, aquariums, natural stretches of game fish waters, ponds, and marine fish farms. Addition to the water and feed and direct application are the associated use forms.
    Type: Application
    Filed: November 22, 2011
    Publication date: March 22, 2012
    Applicant: Bayer CropScience AG
    Inventors: Isolde Häuser-Hahn, Klaus Stenzel, Ulrike Wachendorff-Neumann
  • Publication number: 20110311884
    Abstract: The invention relates to a pentacyclic anion salt and to the use thereof in electrolyte compositions. The compound comprises an inorganic, organic or organometallic cation M of valency m (1?m?3) and m anions corresponding to the formula (I) in which Rf is a —CFZ?Z? group in which Z? is F or a perfluoroalkyl group having from 1 to 3 carbon atoms, and Z? is an H, F or Cl group, an optionally fluorinated or perfluorinated alkoxy group having from 1 to 5 carbon atoms, an optionally fluorinated or perfluorinated oxaalkoxy group having from 1 to 5 carbon atoms or an optionally fluorinated or perfluorinated alkyl group having from 1 to 5 carbon atoms; Z? being other than F when Z? is F. An electrolyte composition comprises said salt in solution in a liquid solvent or a polymer solvent.
    Type: Application
    Filed: August 28, 2009
    Publication date: December 22, 2011
    Inventors: Michel Armand, Sylvie Grugeon, Stephane Laruelle, Maria Bukowska, Przemyslaw Szczecinski, Wladyslaw Wieczorek, Leszek Niedzicki, Bruno Scrosati, Stefania Panero, Priscilla Realle
  • Publication number: 20110269965
    Abstract: Methods and intermediates useful for making compounds of the formula: and the preparation of compounds of Formula I, preferably including the formation of intermediate compounds of the formula:
    Type: Application
    Filed: March 31, 2006
    Publication date: November 3, 2011
    Applicant: Coley Pharmaceutical Group, Inc.
    Inventors: David S. Hays, Sonja S. Mackey, William H. Moser, Doris D. Stoermer, Matthew R. Radmer, Shri Niwas
  • Patent number: 7906724
    Abstract: There is provided novel n-type conjugated compounds based on 2-vinyl-4,5-dicyanoimidazole moieties conjugated via the vinyl group to an aromatic moiety. Also provided are thin films and photovoltaics comprising the novel compounds, as well as methods of synthesizing the compounds.
    Type: Grant
    Filed: July 31, 2007
    Date of Patent: March 15, 2011
    Assignee: Agency for Science, Technology and Research
    Inventors: Alan Sellinger, Richard Yee Cheong Shin, Thomas Kietzke, Zhikuan Chen, Sundarraj Sudhakar
  • Publication number: 20110039705
    Abstract: A method of producing a granular agrochemical composition having excellent handling properties, wherein a powdered agrochemical wettable composition or powdered agrochemical water-soluble composition is converted in form to a granular agrochemical composition, without altering the formulation thereof. The method of producing a granular agrochemical composition includes: treating a powdered agrochemical wettable composition or powdered agrochemical water-soluble composition by (1) a step of adding water, kneading, extruding and drying, (2) a step of adding water, granulating by stirring and drying, (3) a step of adding water, kneading and spray-drying, (4) a step of adding water and performing fluidized bed granulation, or (5) a step of pressure molding the powdered agrochemical wettable composition or powdered agrochemical water-soluble composition; followed by (a) a step of performing microgranulation by grinding, and if necessary, (b) a step of performing grain size regulation by sieving.
    Type: Application
    Filed: April 23, 2009
    Publication date: February 17, 2011
    Inventors: Yoshihisa Endo, Satoru Yamamura
  • Patent number: 7846956
    Abstract: The present invention provides a malononitrile compound represented by the formula (I): wherein any one of X1, X2, X3 and X4 is CR100, wherein R100 is a group represented by the formula: the other three of X1, X2, X3 and X4 each represent nitrogen or CR5, provided that 1 to 3 of X1, X2, X3 and X4 represent nitrogen, and Z represents oxygen, sulfur or NR6, which has pest-controlling activity.
    Type: Grant
    Filed: January 13, 2005
    Date of Patent: December 7, 2010
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Hiromasa Mitsudera, Ken Otaka, Jun Fujiwara
  • Patent number: 7825150
    Abstract: Methods and compositions for treating immunological and inflammatory diseases and disorders are disclosed. Particular methods and compositions comprise the administration of an agent that inhibits S1P lyase activity and at least one additional immunosuppressive and/or anti-inflammatory agent.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: November 2, 2010
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventor: Tamas Oravecz
  • Publication number: 20090326018
    Abstract: The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity. Formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined in the specification, and wherein either the bond between the C1 and C2 carbon atoms is a double bond or the bond between the C2 and C3 carbon atoms is a double bond, R2 being absent when the bond between the C1 and C2 carbon atoms is a double bond.
    Type: Application
    Filed: October 12, 2007
    Publication date: December 31, 2009
    Inventors: Henrik Jernstedt, Lars Krüger, Patrik Rhönnstad, Daniel Nöteberg
  • Publication number: 20080293951
    Abstract: Disclosed is a benzonitrile derivative which is useful as a production intermediate for benzylamine derivative represented by the general formula (5) below and s secondary amine derivative represented by the general formula (9) below. Also disclosed are a method for producing such a benzonitrile derivative and a use thereof as a bactericide. Specifically disclosed are a novel benzonitrile derivative represented by the general formula (1) below, a salt thereof, a production method thereof, and a use thereof as a pharmaceutical intermediate or a bactericide. [Chemical formula 1] (5) (In the formula, n represents an integer of 0-3, and R1 represents a hydrogen, a linear or branched alkyl group having 1-6 carbon atoms or the like.) [Chemical formula 2] (9) (In the formula, n and R1 are a defined above, and R4 represents a hydrogen, a linear or branched alkl group having 1-6 carbon atoms or the like.
    Type: Application
    Filed: August 22, 2006
    Publication date: November 27, 2008
    Inventors: Hideki Iwama, Junko Sudo, Susumu Shimizu, Masataka Katohno, Masashi Yamamoto, Shigeru Suzuki, Hiroshi Hoshino, Nanako Kuruhara
  • Publication number: 20080262241
    Abstract: Methods of preparing imidazole-based compounds are disclosed.
    Type: Application
    Filed: April 11, 2008
    Publication date: October 23, 2008
    Inventors: Wenxue Wu, Jie Yan, Haiming Zhang
  • Patent number: 7259250
    Abstract: A C-nitroso compound having a molecular weight ranging from 225 to 1,000 (from 225 to 600 for oral administration) on a monomeric basis wherein a nitroso group is attached to a tertiary carbon, which is obtained by nitrosylation of a carbon acid having a pKa less than about 25, is useful as an NO donor. When the compound is obtained from a carbon acid with a pKa less than about 10, it provides vascular relaxing effect when used at micromolar concentrations and this activity is potentiated by glutathione to be obtained at nanomolar concentrations. When the compound is obtained from a carbon acid with a pKa ranging from about 15 to about 20, vascular relaxing effect is obtained at nanomolar concentrations without glutathione. In another embodiment, a biocompatible polymer incorporates a C-nitroso moiety.
    Type: Grant
    Filed: February 8, 2005
    Date of Patent: August 21, 2007
    Assignee: Duke University
    Inventors: Jonathan S. Stamler, Eric J. Toone
  • Patent number: 7049308
    Abstract: A C-nitroso compound having a molecular weight ranging from 225 to 1,000 (from 225 to 600 for oral administration) on a monomeric basis wherein a nitroso group is attached to a tertiary carbon, which is obtained by nitrosylation of a carbon acid having a pKa less than about 25, is useful as an NO donor. When the compound is obtained from a carbon acid with a pKa less than about 10, it provides vascular relaxing effect when used at micromolar concentrations and this activity is potentiated by glutathione to be obtained at nanomolar concentrations. When the compound is obtained from a carbon acid with a pKa ranging from about 15 to 20, vascular relaxing effect is obtained at nanomolar concentrations without glutathione. In another embodiment, a biocompatible polymer incorporates a C-nitroso moiety.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: May 23, 2006
    Assignee: Duke University
    Inventors: Jonathan S. Stamler, Eric J. Toone
  • Patent number: 6426360
    Abstract: A class of compounds is described for treating inflammation and inflammation-related disorders.
    Type: Grant
    Filed: May 15, 2000
    Date of Patent: July 30, 2002
    Assignee: G D Searle & Co.
    Inventors: Richard M Weier, Paul W Collins, Michael A Stealey, Thomas E Barta, Renee M Huff
  • Patent number: 6384068
    Abstract: In one embodiment, the invention provides a polymer comprising imidazole ring units having nitrogen at the 1 and 3 positions of the ring; a carbon at each of the 2, 4 and 5 positions of the ring; and radical substituents G1 and G2 carried at the 4 and 5 positions. G1 and G2 are each independently selected from cyano, substituents derived from cyano, and substituents which replace cyano. The polymers formed by at least two of the cyclic imidazole units. In another embodiment, the invention provides new imidazole compounds usable as monomers to form the polymers. In still another embodiment, the invention provides a method for using the polymers as a coupling/activator for synthon synthesis.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: May 7, 2002
    Assignee: The Regents of the University of Michigan
    Inventors: Paul G. Rasmussen, Sarah E. Reybuck, David M. Johnson, Richard G. Lawton
  • Patent number: 6376671
    Abstract: 2-Sulfamoylbenzoic acid derivatives of general formula (I): which have both an antagonistic effect on the leukotriene D4 receptor and an antagonistic effect on the thromboxane A2 receptor and salts thereof, pharmaceuticals, anti-allergic agents and leukotriene-thromboxane A2 antagonistic agents containing them as an active ingredient.
    Type: Grant
    Filed: April 27, 2001
    Date of Patent: April 23, 2002
    Assignee: Kaken Pharmaceutical Co., Ltd.
    Inventors: Yoshihiro Ichikawa, Tokiko Nishida, Jun Nakano, Mitsuru Watanuki, Masahiro Suda, Tsutomu Nakamura
  • Patent number: 6359145
    Abstract: Imidazole compounds having adenosine deaminase inhibitory activity represented by formula (I) wherein R1 is hydrogen, hydroxy, protected hydroxy, or aryl optionally substituted with suitable substituent(s); R2 is hydrogen or lower alkyl; R3 is hydroxy or protected hydroxy; R4 is cyano, (hydroxy)iminoamino(lower)alkyl, carboxy, protected carboxy, heterocyclic group optionally substituted with amino, or carbamoyl optionally substituted with suitable substituent(s); and —A— is —Q— or —O—Q—, wherein Q is single bond or lower alkylene, provided that when R2 is lower alkyl, then R1 is hydroxy, protected hydroxy, or aryl optionally substituted with suitable substituent(s), its prodrug, or their salt. The compounds are useful for treating and/or preventing diseases for which adenosine is effective.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: March 19, 2002
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Tadashi Terasaka, Katsuya Nakamura, Nobuo Seki, Masako Kuno, Susumu Tsujimoto, Akihiro Sato, Isao Nakanishi, Takayoshi Kinoshita, Nobuya Nishio, Hiroyuki Okumura, Kiyoshi Tsuji
  • Patent number: 6288071
    Abstract: Pesticidally active cyclohexadienyl derivative compounds of the formula I that are esters, oximes or amides are claimed. These compounds may be used as fungicides, acaricides and insecticides in plant protection.
    Type: Grant
    Filed: December 10, 1998
    Date of Patent: September 11, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Henry Szczepanski, Martin Zeller, Ottmar Franz Hüter
  • Patent number: 6197973
    Abstract: 3-phenylpyrazoles of formula I wherein R1 is cyano, alkyl or haloalkyl; R2 is cyano or is optionally halogenated alkyl, alkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl; R3 is hydrogen, cyano, halogen, alkyl or haloalkyl; R4 is hydrogen or halogen; R5 is cyano, halogen, or is optionally halogenated alkyl or alkoxy; R6, R7 independently of one another are optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl or phenyl, optionally substituted alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl or optionally halogenated alkylsulfonyl; X is a chemical bond, —C≡C—, —CH2—CH(R8)— or —CH═C(R8)—, wherein R8 is hydrogen, cyano, nitro, halogen, alkyl or haloalkyl; Y is oxygen or sulfur; their preparation and their use for controlling undesirable vegetation.
    Type: Grant
    Filed: February 1, 1999
    Date of Patent: March 6, 2001
    Assignee: BASF Aktiengesellschaft
    Inventors: Cyrill Zagar, Gerhard Hamprecht, Markus Menges, Olaf Menke, Peter Schäfer, Karl-Otto Westphalen, Ulf Misslitz, Helmut Walter